Commun Dis Intell Q Rep. 2006;30(1):129-32. doi: 10.33321/cdi.2006.30.7.
The World Health Organization Western Pacific Region Gonococcal Antimicrobial Surveillance Programme (WHO WPR GASP) examined approximately 10,000 isolates of Neisseria gonorrhoeae from 15 countries for resistance to antibiotics in 2004. Treatment options for gonorrhoea in the Region are limited by persisting high rates of resistance to penicillins and quinolones. There were infrequent instances of spectinomycin resistance and the presence of gonococci with decreased susceptibility to third generation cephalosporins was again noted in several centres.
2004年，世界卫生组织西太平洋区域淋球菌抗菌药物监测项目（WHO WPR GASP）检测了来自15个国家的约10000株淋病奈瑟菌的抗生素耐药性。该区域淋病的治疗选择因对青霉素和喹诺酮类药物持续的高耐药率而受到限制。大观霉素耐药情况罕见，且在几个中心再次发现了对第三代头孢菌素敏感性降低的淋球菌。
